-+ 0.00%
-+ 0.00%
-+ 0.00%
Asia Pacific Pharmaceutical announced that Zhejiang Yatai Xinghao Pharmaceutical Co., Ltd., a holding subsidiary of the company, recently obtained the “Pharmaceutical Business License” issued by the Zhejiang Drug Administration. The license number is Zhejiang AA575000040. The business method is wholesale, and the business scope is proprietary Chinese medicines and chemicals, which is valid until November 5, 2031. Obtaining the license this time indicates that Yatai Xinghao is qualified to carry out pharmaceutical wholesale and distribution business in accordance with the law, which will help improve the company's layout in the pharmaceutical industry chain, but it will not have a significant impact on the company's performance in the short term.
Share
Listen to the news
Asia Pacific Pharmaceutical announced that Zhejiang Yatai Xinghao Pharmaceutical Co., Ltd., a holding subsidiary of the company, recently obtained the “Pharmaceutical Business License” issued by the Zhejiang Drug Administration. The license number is Zhejiang AA575000040. The business method is wholesale, and the business scope is proprietary Chinese medicines and chemicals, which is valid until November 5, 2031. Obtaining the license this time indicates that Yatai Xinghao is qualified to carry out pharmaceutical wholesale and distribution business in accordance with the law, which will help improve the company's layout in the pharmaceutical industry chain, but it will not have a significant impact on the company's performance in the short term.
Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.
What's Trending